News from veridex, llc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Apr 03, 2013, 14:25 ET

Next-Generation Circulating Tumor Cell Test Demonstrates High Efficiency and Accuracy in New Study

Veridex, LLC (Veridex) announced today that the first study of the company's next-generation circulating tumor cell (CTC) technology, developed in...

Jan 17, 2013, 08:30 ET

Veridex and LabCorp Agreement Brings CELLSEARCH® CTC Test to China

Veridex, LLC today announced an agreement with LabCorp Clinical Trials that makes the CELLSEARCH® circulating tumor cell (CTC) test available...

Dec 27, 2012, 08:00 ET

New Category I CPT Codes and Payment Rates for Circulating Tumor Cell Testing Effective January 1

Veridex, LLC today announced that new Category I Current Procedural Technology (CPT) codes for circulating tumor cell (CTC) testing will go into...

Dec 12, 2012, 17:30 ET

CellSearch® 'Liquid Biopsy' Approved for Breast Cancer Patients in China

 Veridex, LLC today announced approval from the China State Food & Drug Administration (SFDA) for the CellSearch® circulating tumor...

Aug 09, 2012, 09:00 ET

Updated Coding and Payment on the Horizon for Circulating Tumor Cell Testing

 Veridex, LLC today announced that the Centers for Medicare and Medicaid Services (CMS) will determine payment rates for two new Current...

Apr 23, 2012, 11:13 ET

New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer

 Veridex, LLC announced today that it has joined with Novartis Pharmaceuticals Corporation in an educational alliance to encourage and...

Mar 21, 2012, 15:09 ET

Investigational Study May Help Researchers Develop Test that Predicts Risk of Imminent Heart Attacks

RARITAN, N.J., March 21, 2012 /PRNewswire/ — Veridex, LLC today announced the publication of a new, investigational study published...

Jun 04, 2011, 14:30 ET

Late-Breaking ASCO Data Demonstrate Circulating Tumor Cells as Potential Biomarker for Metastatic Prostate Cancer Clinical Trials

Data presented at the 47th American Society of Clinical Oncology (ASCO) annual meeting demonstrate the potential of circulating tumor cells (CTC)...

May 24, 2011, 07:30 ET

Veridex Launches CELLTRACKS® Circulating Melanoma Cell Kit for Research Use

Veridex, LLC today announced the launch of the CELLTRACKS® Circulating Melanoma Cell (CMC) kit, providing research scientists with a fast,...

Jan 03, 2011, 07:30 ET

Veridex, LLC Announces Collaboration to Develop Next-Generation Circulating Tumor Cell (CTC) Technology with Massachusetts General Hospital

Veridex, LLC (Veridex) today announced a collaboration with Massachusetts General Hospital to develop and commercialize a next-generation...

Jul 13, 2009, 08:45 ET

Monitoring Circulating Tumor Cells With the CellSearch(R) System Can Predict Prognosis in Metastatic Breast Cancer

Measuring the change in circulating tumor cell (CTC) count can accurately predict the prognosis and survival in patients with metastatic breast...

May 07, 2009, 09:00 ET

CellSearch(R) System to Be Offered at Florida Cancer Specialists

Proprietary Veridex Technology is the First Cancer Diagnostic Test to Automate and Capture Circulating Tumor Cells Veridex, LLC announced today...

Nov 12, 2008, 10:45 ET

Cleveland Clinic Recognizes Circulating Tumor Cell Technology as Top Medical Innovation for 2009

Veridex, LLC announced today that the technology used in the CellSearch(R) System to measure circulating tumor cells (CTCs) was ranked as the top...

Jun 11, 2008, 01:00 ET

Veridex Announces Agreement to Acquire the Assets of Immunicon Corporation

RARITAN, N.J., June 11 /PRNewswire-FirstCall/ -- Veridex, LLC announced today that it has signed an asset purchase agreement to acquire...

May 16, 2008, 01:00 ET

New Gene Methylation Test for Prostate Cancer Available

RARITAN, N.J., May 16 /PRNewswire/ -- Veridex, LLC announced today that its licensing collaborator, Laboratory Corporation of America Holdings...

Feb 27, 2008, 00:00 ET

FDA Clears Cellsearch(TM) Circulating Tumor Cell Test for Monitoring Metastatic Prostate Cancer Patients

RARITAN, N.J., Feb. 27 /PRNewswire/ -- Veridex, LLC today announced that the U.S. Food and Drug Administration (FDA) has granted an expanded...

Nov 20, 2007, 00:00 ET

FDA Clears Advanced Test for Monitoring Metastatic Colorectal Cancer

WARREN, N.J., Nov. 20 /PRNewswire-USNewswire/ -- Veridex, LLC today announced that the U.S. Food and Drug Administration (FDA) has granted an...

Jul 16, 2007, 01:00 ET

FDA Approves First Gene-Based Test to Detect the Spread of Breast Cancer Into Lymph Nodes

WARREN, N.J., July 16 /PRNewswire-USNewswire/ -- Veridex, LLC, a Johnson & Johnson company, has announced U.S. Food and Drug Administration...

Dec 18, 2006, 00:00 ET

Study Results Show GeneSearch(TM) Breast Lymph Node Assay Rapidly Detects Breast Cancer Metastases With Greater Sensitivity Than Traditional Tests

SAN ANTONIO, Dec. 18 /PRNewswire/ -- Results from a prospective clinical study show that the GeneSearch(TM) Breast Lymph Node (BLN) Assay, a...

Dec 16, 2006, 00:00 ET

Study Results Show GeneSearch(TM) Breast Lymph Node Assay Rapidly Detects Breast Cancer Metastases With Greater Sensitivity Than Traditional Tests

SAN ANTONIO, Dec. 16 /PRNewswire/ -- Results from a prospective clinical study show that the GeneSearch(TM) Breast Lymph Node (BLN) Assay, a...